Helena Edlund

Helena Edlund is a Swedish professor and molecular biologist. She received her Ph.D. from Umeå University in 1991.[1] She is a professor in Molecular Developmental Biology at Umeå University where she researches Type 2 diabetes and β-cell function.[2] She is one of the founders, along with Thomas Edlund and Olof Karlsson, of the biopharmaceutical company Betagenon.[3]

In 2000, Edlund was the recipient of the Minkowski Prize given by the European Association for the Study of Diabetes (EASD) for her work in factors controlling beta-cell identity and glucose homeostasis.[4] She is a member of the Royal Swedish Academy of Sciences. She has written numerous articles on beta cell differentiation, beta cell function, pancreatic development, and Type 2 diabetes.[1]

References
  1. "Helena Edlund". ORCID. Retrieved 4 November 2021.
  2. "Grp Helena Edlund". Umeå University. Retrieved 4 November 2021.
  3. "Management". Betagenon. Retrieved 4 November 2021.
  4. "Minkowski". EASD. Retrieved 4 November 2021.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.